Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus MeetingNiven Mehra, Margreet G.E.M. Ausems, Chris H. Bangma et al.|European Urology Open Science|2023Cited by 10
Preventive dendritic cell vaccination in healthy Lynch syndrome mutation carriersHarm Westdorp, I. Jolanda M. de Vries, Mark A.J. Gorris et al.|Annals of Oncology|2016Cited by 8
How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary ViewDaniela E. Oprea‐Lager, Niven Mehra, Tessa van Elst et al.|European Urology Open Science|2025Cited by 4
Preventive dendritic cell vaccination induced TGF-βRII frameshift neoantigen-specific T-cells are linked to long-term disease-free survival in Lynch Syndrome patientsI. Jolanda M. de Vries, Asima Abidi, Harm Westdorp et al.|Research Square|2025Cited by 3
Discrepancies Between Global Consensus and Local Implementation in the Management of Advanced Prostate CancerNiven Mehra, Peter-Paul M. Willemse, Daniela E. Oprea-Lager et al.|European Urology Open Science|2026Cited by 0